Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.

[1]  J. Fries,et al.  The relative toxicity of nonsteroidal antiinflammatory drugs. , 2010, Arthritis and rheumatism.

[2]  S. Hill,et al.  Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis , 1996, BMJ.

[3]  K. Brandt,et al.  Practical management of osteoarthritis. Integration of pharmacologic and nonpharmacologic measures. , 1995, Archives of family medicine.

[4]  E. Tindall,et al.  Misoprostol Dosage in the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Gastric and Duodenal Ulcers: A Comparison of Three Regimens , 1995, Annals of Internal Medicine.

[5]  J. Senior,et al.  Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs , 1995, Annals of Internal Medicine.

[6]  N. Dreyer,et al.  Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study. , 1995, Archives of internal medicine.

[7]  W. Ray,et al.  Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. , 1995, American journal of epidemiology.

[8]  P. Kwo,et al.  Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature. , 1995, Mayo Clinic proceedings.

[9]  R. Stern,et al.  Severe adverse cutaneous reactions to drugs. , 1994, The New England journal of medicine.

[10]  R J Glynn,et al.  Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. , 1994, JAMA.

[11]  D. Hogan,et al.  Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[12]  D. Puett,et al.  Published Trials of Nonmedicinal and Noninvasive Therapies for Hip and Knee Osteoarthritis , 1994, Annals of Internal Medicine.

[13]  M. Rawlins,et al.  Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs , 1994, The Lancet.

[14]  H. Jick,et al.  Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs , 1994, The Lancet.

[15]  I. Russell,et al.  Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. , 1993, Arthritis and rheumatism.

[16]  K. Brandt.  Should osteoarthritis be treated with nonsteroidal anti-inflammatory drugs? , 1993, Rheumatic diseases clinics of North America.

[17]  P. Dieppe,et al.  A two-year, placebo-controlled trial of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint. , 1993, British journal of rheumatology.

[18]  R. Wallace,et al.  Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population. , 1993, Journal of gerontology.

[19]  Y. Friedlander,et al.  Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. , 1993, British journal of clinical pharmacology.

[20]  S. Gabriel,et al.  The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events. , 1993, Arthritis and rheumatism.

[21]  D. Henry,et al.  Nonsteroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales. , 1993, Gastroenterology.

[22]  D. Felson,et al.  A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. , 1993, Archives of internal medicine.

[23]  P. Dieppe,et al.  Is research into the treatment of osteoarthritis with non-steroidal anti-inflammatory drugs misdirected? , 1993, The Lancet.

[24]  P. Benfield,et al.  Misoprostol , 1993, PharmacoEconomics.

[25]  T. Borody,et al.  Helicobacter pylori-negative gastric ulcer , 1992, The American journal of gastroenterology.

[26]  Y. Yazaki,et al.  Multiple strictures of the small intestine after long-term nonsteroidal anti-inflammatory drug therapy. , 1992, The American journal of gastroenterology.

[27]  A M Walker,et al.  Nonsteroidal Antiinflammatory Drugs and Gastrointestinal Hospitalizations in Saskatchewan: A Cohort Study , 1992, Epidemiology.

[28]  W. Ray,et al.  Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. , 1992, Journal of gerontology.

[29]  A. Zinsmeister,et al.  Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. , 1992, Gastroenterology.

[30]  J. Rhodes,et al.  ARE NON‐STEROIDAL ANTI‐INFLAMMATORY DRUGS ALWAYS NECESSARY? A GENERAL PRACTICE SURVEY , 1992, The British journal of clinical practice.

[31]  A. Walker,et al.  The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. , 1992, Archives of internal medicine.

[32]  D. Mccarty,et al.  Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. , 1992, The Journal of rheumatology.

[33]  S. Gabriel,et al.  Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. , 1991, Annals of internal medicine.

[34]  J. Fries,et al.  Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. , 1991, The American journal of medicine.

[35]  T. Borody,et al.  Helicobacter pylori-negative duodenal ulcer. , 1991, The American journal of gastroenterology.

[36]  M. Liang,et al.  Management of osteoarthritis of the hip and knee. , 1991, The New England journal of medicine.

[37]  K. Brandt,et al.  Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. , 1991, The New England journal of medicine.

[38]  T. Schubert,et al.  Helicobacter pylori-negative duodenal ulcer. , 1991, The American journal of medicine.

[39]  C. Hamilton,et al.  Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney Function , 1991, Journal of clinical pharmacology.

[40]  R. Day,et al.  Nonsteroidal antiinflammatory drugs--differences and similarities. , 1991, The New England journal of medicine.

[41]  D. Graham,et al.  Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. , 1991, Gastroenterology.

[42]  A. Dobson,et al.  NSAIDs and risk of upper gastrointestinal bleeding , 1991, The Lancet.

[43]  Graves Ej,et al.  Detailed diagnoses and procedures, National Hospital Discharge Survey, 1994. , 1997, Vital and health statistics. Series 13, Data from the National Health Survey.

[44]  W. Ray,et al.  Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. , 1991, Annals of internal medicine.

[45]  X. Vidal,et al.  Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs , 1991, The Lancet.

[46]  L. Pedersen,et al.  Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study , 1990, Pain.

[47]  R. Wallace,et al.  Prevalence and Characteristics of Multiple Analgesic Drug Use in an Elderly Study Group , 1990, Journal of the American Geriatrics Society.

[48]  W. Ray,et al.  Adverse drug reactions and the elderly. , 1990, Health affairs.

[49]  M. Drummond,et al.  Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs. , 1990, Postgraduate medical journal.

[50]  A. Tosteson,et al.  Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding. , 1990, JAMA.

[51]  D. Klassen,et al.  Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison. , 1990, Annals of internal medicine.

[52]  M. Murray,et al.  Adverse effects of nonsteroidal anti-inflammatory drugs on renal function. , 1990, Annals of internal medicine.

[53]  T. Shallcross,et al.  Effect of non-steroidal anti-inflammatory drugs on dyspeptic symptoms. , 1990, BMJ.

[54]  Stillman Mt,et al.  Nonsteroidal anti-inflammatory drug nephrotoxicity. Should we be concerned? , 1990 .

[55]  D. Mellström,et al.  Incidence of peptic ulcer disease in Gothenburg, 1985. , 1989, BMJ.

[56]  Peura Da,et al.  Campylobacter pylori, NSAIDS, and smoking: risk factors for peptic ulcer disease. , 1989 .

[57]  B. Bloom,et al.  Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs. , 1989, Archives of internal medicine.

[58]  G. Carrin,et al.  Economic evaluation of prophylactic treatment with Misoprostol in osteoarthritic patients treated with NSAIDs. The case of Belgium. , 1989, Revue d'epidemiologie et de sante publique.

[59]  B. Bloom.  Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs. , 1989, Archives of internal medicine.

[60]  C. Bulpitt,et al.  Joint pain and quality of life; results of a randomised trial. , 1989, British journal of clinical pharmacology.

[61]  W. Schaffner,et al.  Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. , 1988, Annals of internal medicine.

[62]  K. Steele,et al.  Non-steroidal anti-inflammatory drugs--prescribe with caution. , 1988, The Journal of the Royal College of General Practitioners.

[63]  D. Brater.  Clinical aspects of renal prostaglandins and NSAID therapy. , 1988, Seminars in arthritis and rheumatism.

[64]  U Bergman,et al.  Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. , 1988, Journal of clinical epidemiology.

[65]  K. Radack,et al.  Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. , 1987, Annals of internal medicine.

[66]  D. Graham,et al.  Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. , 1987, The American journal of gastroenterology.

[67]  A. Levi,et al.  BLOOD AND PROTEIN LOSS VIA SMALL-INTESTINAL INFLAMMATION INDUCED BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS , 1987, The Lancet.

[68]  P. Stolley,et al.  The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. , 1987, Archives of internal medicine.

[69]  R. Toto,et al.  Effects of nonsteroidal antiinflammatory drugs on renal function in patients with renal insufficiency and in cirrhotics. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[70]  P. Landais,et al.  Analgesic and non-steroidal anti-inflammatory drug-associated acute renal failure: a prospective collaborative study. , 1986, Clinical nephrology.

[71]  J. Spence,et al.  EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON CONTROL OF HYPERTENSION BY BETA-BLOCKERS AND DIURETICS , 1986, The Lancet.

[72]  M. Langman,et al.  NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLEEDING PEPTIC ULCER , 1986, The Lancet.

[73]  M. Dunn,et al.  The role of prostaglandins in human hypertension. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[74]  M. Langman,et al.  Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. , 1985, British medical journal.

[75]  D M Clive,et al.  Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.

[76]  W. Hale,et al.  Analgesic Drug Use in an Ambulatory Elderly Population , 1982, Drug intelligence & clinical pharmacy.

[77]  D. Catovsky,et al.  SCANNING ELECTRON MICROSCOPY AND THE NATURE OF THE HAIRY CELL , 1975, The Lancet.

[78]  J. Davis.  Letter: Diphenylhydantoin for hiccups. , 1974, Lancet.

[79]  J. A. Mills.  Nonsteroidal Anti-Inflammatory Drugs , 1974 .

[80]  A. Siegelaub,et al.  Cigarettes, alcohol, coffee and peptic ulcer. , 1974, The New England journal of medicine.

[81]  P. Berger.  Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years , 1996 .

[82]  R L Savage,et al.  Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. , 1993, Arthritis and rheumatism.

[83]  S. Gabriel,et al.  Patient preferences for nonsteroidal antiinflammatory drug related gastrointestinal complications and their prophylaxis. , 1993, The Journal of rheumatology.

[84]  A. Jones,et al.  Non-steroidal anti-inflammatory drug usage and requirement in elderly acute hospital admissions. , 1992, British journal of rheumatology.

[85]  G. Pouvourville.  The Economic Consequences of NSAID-Induced Gastropathy: The French Context , 1992 .

[86]  W. Campbell,et al.  Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men. , 1985, Kidney international.